Tag: EX1

Exopharm ASX EX1 Plexaris anti cancer drug doxorubicin Plexodox

Exopharm developing novel Plexaris product to deliver anti-cancer drug into target cells

Clinical stage regenerative medicine company Exopharm (ASX: EX1) has published test results that suggest its Plexaris product, made up of engineered exosomes through “LEAP technology”, can effectively...
Exopharm ASX EX1 publishes results exosome Plexaris Cevaris BioMAP

Exopharm publishes ‘positive and unique’ results for its exosome platform

Regenerative medicine company Exopharm (ASX: EX1) has received amiable results from a BioMAP testing program operated by Eurofins with respect to its exosome products. Results showed that Exopharm’...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS